Medicofarma Biotech SA (WSE:MDB)
Poland
· Delayed Price · Currency is PLN 0.2900
0.00 (0.00%)
At close: May 9, 2025
Medicofarma Biotech Revenue
In the year 2024, Medicofarma Biotech had annual revenue of 1.22M PLN with 63.14% growth. Medicofarma Biotech had revenue of 161.55K in the quarter ending December 31, 2024, with 3,571.50% growth.
Revenue
1.22M
Revenue Growth
+63.14%
P/S Ratio
15.87
Revenue / Employee
61.24K
Employees
20
Market Cap
19.44M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.22M | 474.05K | 63.14% |
| Dec 31, 2023 | 750.81K | -3.50M | -82.34% |
| Dec 31, 2022 | 4.25M | 915.81K | 27.45% |
| Dec 31, 2021 | 3.34M | -313.69K | -8.59% |
| Dec 31, 2020 | 3.65M | 465.77K | 14.63% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 12.61B |
| Synektik Spólka Akcyjna | 556.63M |
| Voxel | 507.77M |
| Celon Pharma | 209.54M |
| Ryvu Therapeutics | 101.96M |
| Selvita | 345.76M |
| Centrum Medyczne ENEL-MED | 735.59M |
| EMC Instytut Medyczny | 809.41M |